Understanding Long-Term Safety, Efficacy, and Demographic Variances in Ruxolitinib Trials

  • Alexandra Golant

Press/Media

Period1 Apr 2024

Media coverage

1

Media coverage

  • TitleUnderstanding Long-Term Safety, Efficacy, and Demographic Variances in Ruxolitinib Trials
    Media name/outletDermatology Times
    Country/TerritoryUnited States
    Date1/04/24
    PersonsAlexandra Golant
View all 1
View less